ATE417050T1 - Verbindungen als semaphorininhibitoren - Google Patents

Verbindungen als semaphorininhibitoren

Info

Publication number
ATE417050T1
ATE417050T1 AT03731824T AT03731824T ATE417050T1 AT E417050 T1 ATE417050 T1 AT E417050T1 AT 03731824 T AT03731824 T AT 03731824T AT 03731824 T AT03731824 T AT 03731824T AT E417050 T1 ATE417050 T1 AT E417050T1
Authority
AT
Austria
Prior art keywords
compounds
semaphorin
independently hydrogen
semaphorin inhibitors
inhibitors
Prior art date
Application number
AT03731824T
Other languages
English (en)
Inventor
Kazuo Kumagai
Nobuo Hosotani
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE417050T1 publication Critical patent/ATE417050T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT03731824T 2002-01-24 2003-01-22 Verbindungen als semaphorininhibitoren ATE417050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002015216 2002-01-24

Publications (1)

Publication Number Publication Date
ATE417050T1 true ATE417050T1 (de) 2008-12-15

Family

ID=27606106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03731824T ATE417050T1 (de) 2002-01-24 2003-01-22 Verbindungen als semaphorininhibitoren

Country Status (7)

Country Link
US (1) US7642362B2 (de)
EP (1) EP1475382B1 (de)
JP (3) JP4549675B2 (de)
AT (1) ATE417050T1 (de)
DE (1) DE60325172D1 (de)
ES (1) ES2316763T3 (de)
WO (1) WO2003062243A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4820170B2 (ja) * 2003-12-05 2011-11-24 大日本住友製薬株式会社 虚血性神経障害治療又は予防剤
CN103379906B (zh) 2011-02-25 2016-01-20 学校法人庆应义塾 用于角膜感觉神经损伤的包含脑信号蛋白抑制剂作为活性成分的治疗剂
US10323024B2 (en) 2016-01-15 2019-06-18 Sumitomo Dainippon Pharma Co., Ltd. Biheterocyclic compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06506202A (ja) 1991-03-22 1994-07-14 ゼノバ リミテッド 医薬用キサントン誘導体
US5229123A (en) * 1991-10-09 1993-07-20 Hoffmann-La Roche Inc. Antifungal agents
US5416197A (en) * 1993-10-15 1995-05-16 Trustees Of The University Of Pennsylvania Antibodies which bind human collapsin
JP4108755B2 (ja) 1996-09-11 2008-06-25 大日本住友製薬株式会社 新規セマフォリン遺伝子:セマフォリンy
AU4398997A (en) 1996-10-09 1998-05-05 Sumitomo Pharmaceuticals Company, Limited Novel semaphorin gene: semaphorin w
DE60130769T2 (de) * 2000-07-28 2008-07-17 Dainippon Sumitomo Pharma Co., Ltd. Förderer der nervenregeneration die als aktiven bestandteil einen semaphorinhemmer enthalten

Also Published As

Publication number Publication date
DE60325172D1 (de) 2009-01-22
JP4549675B2 (ja) 2010-09-22
EP1475382A4 (de) 2005-05-11
JP2010013480A (ja) 2010-01-21
JP2011046734A (ja) 2011-03-10
US7642362B2 (en) 2010-01-05
ES2316763T3 (es) 2009-04-16
JPWO2003062243A1 (ja) 2005-05-19
EP1475382A1 (de) 2004-11-10
US20050119334A1 (en) 2005-06-02
WO2003062243A1 (en) 2003-07-31
EP1475382B1 (de) 2008-12-10

Similar Documents

Publication Publication Date Title
BRPI0610312B8 (pt) dispositivo de assistência à caminhada
MY132698A (en) Herbicidal composition
TNSN08174A1 (en) Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
TW200505902A (en) Cannabinoid receptor ligands
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
EP1704856A4 (de) Proteininhibitor der hsp90-familie
EP1674452A4 (de) Neues 4-phenylaminobenzaldoximderivatie und dessen verwendung als mek-inhibitor
DE60027144D1 (de) Hydroxamsäure-derivate
DE60234164D1 (de) Neues a-liponsäurederivat und dessen verwendung
EP1314712A4 (de) Substituierte benzoesäurederivate als nf-kappa-b-inhibitoren
DE69920923D1 (de) Anthranilsäurederivate
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
MXPA05006450A (es) Nuevo derivado de 2,4-diamino-1,3,5-triazina.
UA96149C2 (en) Method for producing 4-oxoquinoline compound
EP1191022A4 (de) Neuartige dihydropyridin-derivate
DE60325172D1 (de) Verbindungen als semaphorininhibitoren
IL157440A0 (en) Triazole derivatives and pharmaceutical compositions containing the same
ATE206125T1 (de) Furoindolizine
BR0108810A (pt) Novos agentes antibacterianos de benzosultam oxazolidinona
NO20065789L (no) Cinnamidforbindelse
NO20053208D0 (no) Metode for reduktiv dehalogenering.
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
BRPI0406990A (pt) Derivado de oligossacarìdeo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties